The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrickability Group Regulatory News (BRCK)

Share Price Information for Brickability Group (BRCK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.50
Bid: 71.00
Ask: 72.00
Change: -0.80 (-1.11%)
Spread: 1.00 (1.408%)
Open: 71.80
High: 71.80
Low: 71.50
Prev. Close: 72.30
BRCK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Non-Executive Director

9 Aug 2022 07:00

RNS Number : 3035V
Brickability Group PLC
09 August 2022
 

Brickability Group PLC 

LEI: 213800SK28MWXB3K3P26 

9 August 2022

 

Brickability Group plc

("Brickability" or "the Group")

 

Appointment of Independent Non-Executive Director

 

Brickability Group plc (AIM: BRCK), the leading construction materials distributor, is pleased to announce the appointment of Sharon Collins as an Independent Non-Executive Director of the Group with effect from 6 September 2022, on conclusion of the Company's 2022 Annual General Meeting.

 

Sharon has more than 20 year's experience predominantly in marketing, international sales and business development roles within the Healthcare sector. Having previously worked for a leading dental manufacturer for seven years, Sharon also spent five years within the International Business Development field with Sinclair Pharmaceuticals. Sharon qualified from Lancaster University in 1996 with a degree in Marketing and gained her MBA (with Distinction) in 2005.

 

In 2010, she co-founded Venture Life Group, which was subsequently floated on AIM, and is currently Chief Commercial Officer and Board Director of the Venture Life Group; Sharon is responsible for the international expansion of the business and its 'Buy and Build' strategy, delivered through acquisition, integration, and growth.

 

John Richards, Chairman, commented:

"I am delighted to welcome Sharon to the Brickability Board as an independent non-executive director. Sharon's depth of relevant experience will no doubt add significant value to the Board and we very much look forward to working with Sharon as Brickability continues to execute its stated strategy."

 

Regulatory Disclosures:

 

In accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies, Sharon Mary Daly (nee Collins), aged 47, has held the following directorships in the past five years:

Current Directorships:

 

- Venture Life Group Plc

- Venture Life Limited

- Venture Life Healthcare Limited

- Venture Life Manufacturing (Sweden) AB

- Periproducts Limited

- Lubatti Limited

- Kullgren Holding AB

- Rolf Kullgren AB

 

Directorships held in the past five years:

 

- Tracy Malone Originals Limited

 

Sharon Collins does not currently hold any ordinary shares in the Company.

 

For further information please contact:

 

Brickability Group plc

John Richards, Chairman

Alan Simpson, CEO

Mike Gant, CFO

via Montfort Communications

 

Cenkos Securities plc (Nominated adviser and broker)

Ben Jeynes, Max Gould (Corporate Finance)

Julian Morse, Alex Pollen (Sales)

+44 (0) 20 7397 8900

 

Montfort Communications

James Olley

Georgia Colkin

 +44 (0) 203 514 0897

 

 

About Brickability 

 

Brickability is a leading construction materials distributor, serving customers across the UK and Europe for over 36 years through its national and local networks. The Group supplies over 550m bricks annually and has over 55 locations across the country with over 600 employees.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGGRDRNGZZM
Date   Source Headline
9th May 202410:11 amRNSDirector/PDMR Shareholding
1st May 20243:31 pmRNSTotal Voting Rights
26th Apr 20247:00 amRNSPre-Close Trading Update
15th Apr 20247:00 amRNSConfirmation of CEO start date
2nd Apr 202411:30 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSChange of Adviser
12th Mar 20246:10 pmRNSAIM Rule 17 Disclosure
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 202411:25 amRNSDirector/PDMR Shareholding
5th Mar 20243:21 pmRNSHolding(s) in Company
4th Mar 20244:32 pmRNSHolding(s) in Company
1st Mar 20248:27 amRNSTotal Voting Rights
28th Feb 20249:45 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSTrading Update
26th Feb 20245:42 pmRNSDirector/PDMR Shareholding
20th Feb 20243:50 pmRNSHolding(s) in Company
8th Feb 20242:11 pmRNSHolding(s) in Company
1st Feb 20245:11 pmRNSBlock listing six monthly returns
1st Feb 20245:08 pmRNSTotal Voting Rights
1st Feb 20245:03 pmRNSDirector/PDMR Shareholding
30th Jan 20245:03 pmRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 202410:12 amRNSGrant of Options
24th Jan 20245:35 pmRNSDirector/PDMR Shareholding
24th Jan 20243:39 pmRNSHolding(s) in Company
24th Jan 20243:36 pmRNSHolding(s) in Company
23rd Jan 202411:47 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSAcquisition of TSL Assets Limited
2nd Jan 20246:10 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for six months ended 30 Sept 2023
22nd Nov 20237:00 amRNSInvestor Presentation via Investor Meet Company
22nd Nov 20237:00 amRNSVesting of LTIP Awards and PDMR Shareholding
21st Nov 20237:00 amRNSNotice of Interim Results and Analyst Presentation
17th Nov 20237:00 amRNSBlock Admission
23rd Oct 20232:13 pmRNSChange of Nominated Adviser and Broker
20th Oct 20239:25 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSTrading Update & Acquisition
5th Sep 20238:30 amRNSAGM Statement
31st Aug 20235:19 pmRNSTotal Voting Rights
2nd Aug 20239:06 amRNSBlock listing Interim Review
25th Jul 202311:09 amRNS2023 Annual Report and Notice of AGM
21st Jul 20232:17 pmRNSHolding(s) in Company
17th Jul 20231:41 pmRNSInvestor Presentation via Investor Meet Company
17th Jul 20237:00 amRNSFinal results for the year ended 31 March 2023
10th Jul 20237:00 amRNSNotice of Results & Analyst Presentation
26th May 20237:00 amRNSChief Executive Officer Succession
26th Apr 20237:00 amRNSPre-Close Trading Update
14th Apr 20233:44 pmRNSHolding(s) in Company
4th Apr 20239:08 amRNSTotal Voting Rights
3rd Mar 20237:00 amRNSResignation of Independent Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.